FDA/CDC

FDA to recommend limits on heavy metals in baby foods


 

The Food and Drug Administration has responded to congressional criticism and launched a multiyear plan to reduce the amount of heavy metals such as mercury and arsenic found in baby food.

Catherine Delahaye/DigitalVision/Getty Images

Called “Closer to Zero,” the FDA plan calls for continued scientific investigation, establishes acceptable levels of heavy metals, sets up a way to monitor manufacturers’ compliance, and sets “action levels.”

“Although the FDA’s testing shows that children are not at an immediate health risk from exposure to toxic elements at the levels found in foods, we are starting the plan’s work immediately, with both short- and long-term goals for achieving continued improvements in reducing levels of toxic elements in these foods over time,” the FDA said.

However, Closer to Zero will only make recommendations on heavy metal levels.

“Although action levels are not binding, we have seen that, over the years, our guidance on action levels and other actions have contributed to significant reductions of toxic elements in food,” an FDA spokeswoman wrote in a statement, according to the Washington Post.

A congressional panel said in February 2021 that major brands of commercial baby food routinely have high levels of toxic heavy metals. The House Oversight Committee said this leaves babies at risk for serious developmental and neurologic problems.

The committee sharply criticized the FDA for not taking action.

“Despite the well-known risks of harm to babies from toxic heavy metals, FDA has not taken adequate steps to decrease their presence in baby foods,” the committee said. “FDA has not issued thresholds for the vast majority of toxic heavy metals in baby foods and does not require warning labels on any baby food products.”

A version of this article first appeared on WebMD.com.

Recommended Reading

Is metformin effective for reducing weight in obese or overweight adolescents?
MDedge Family Medicine
Can smoke exposure inform CRC surveillance in IBD?
MDedge Family Medicine
Psychological difficulties persist among patients with IBD
MDedge Family Medicine
ACG: CRC screening should start at age 45
MDedge Family Medicine
Swallowable capsule-camera may reveal GI cancers, diseases
MDedge Family Medicine
Adherence to antireflux lifestyle factors shows benefit in women
MDedge Family Medicine
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
MDedge Family Medicine
FDA approves first AI device to detect colon lesions
MDedge Family Medicine
Verification bias casts doubt on IgA tTG in celiac disease
MDedge Family Medicine
Microbiota-directed therapy may improve growth rate in malnourished children
MDedge Family Medicine